{
  "ptid_time": "012_S_4026_2011-08-30",
  "img_path": "/data/qiuhui/data/adni/images/012_S_4026/2011-08-30/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 7,440 mm³, 1.6% below the reference mean. With a Z-score of -0.15 (43.9th percentile), this represents normal volume ; whole brain volume measures 1,089,850 mm³, 1.0% above the reference mean. With a Z-score of 0.13 (55.0th percentile), this represents normal volume ; entorhinal cortex volume measures 3,658 mm³, 10.8% below the reference mean. With a Z-score of -0.73 (23.2th percentile), this represents normal volume ; fusiform gyrus volume measures 20,680 mm³, 9.8% above the reference mean. With a Z-score of 0.83 (79.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,280 mm³, 4.4% above the reference mean. With a Z-score of 0.40 (65.4th percentile), this represents normal volume . ",
  "text_data": "Age is 73.5 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities. MMSE: 29.0. MoCA: 24.0. Logical Memory: 15.0. Laboratory findings: Eosinophils: 0.33 (significant elevated); Serum Glucose: 203.00 (profound elevated); Alkaline Phosphatase: 32.00 (significant reduced); LDH: 101.00 (profound reduced); Cholesterol (High Performance): 118.00 (significant reduced). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.22 SUVR (mild elevated); Amyloid beta: 509.20 pg/mL (mild reduced); Total tau: 197.80 pg/mL (normal ); Phosphorylated tau: 18.33 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal and whole brain volumes are within normal ranges, though the entorhinal cortex shows mild atrophy (10.8% below mean, Z-score -0.73). Cognitive testing (MMSE 29, MoCA 24) suggests slight impairment, and biomarker data (mildly reduced Aβ, mildly elevated AV45) indicate early amyloid pathology. However, tau markers are normal, and there is no APOE4 risk allele.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores suggest subtle decline, and amyloid/tau biomarkers are not strongly abnormal, but entorhinal cortex atrophy raises concern for early neurodegenerative changes.)",
  "timestamp": "2025-07-25T23:10:38.655220"
}